Filing excerpt
See Note 2 for a discussion of our acquisition of Metsera in November 2025 and other recent business development initiatives.
sec.gov/Archives/edgar/data/78003/000007800326000054/pfe-20260329.htmRead the full source
Pfizer10-Q: Restructuring charge
Pfizer integrating Metsera acquisition from Nov 2025, incurring acquisition-related costs.
Source: Autobound Signal API · 97 signals tracked for Pfizer · updated
Get Pfizer's live signals in Claude or ChatGPT, or by API
Ask
What changed at Pfizer this week? Use Autobound signals for pfizer.com.What happened
Following its recent acquisition of Metsera, Pfizer is incurring acquisition-related costs.
Source
Other signals in this filing (4)
- RestructuringPfizer's acquisition of Metsera in Nov 2025 signals major integration projects in 2026.Restructuring
- Acquisition completedPfizer completed acquisition of Metsera in November 2025 as part of its business development strategy.Acquisition completed
- Margin pressurePfizer's income growth is being offset by rising Cost of Sales and R&D expenses.Margin pressure
- Bookings declinePfizer reports continued revenue decline from COVID-19 products Comirnaty and Paxlovid.Bookings decline
Extracted by Autobound
From the Signal API record- Signal
- 10-Q: Restructuring charge
What this signalsFilings often name leadership changes, deals and spending plans.
- Fiscal year end
- 03/29
- Filed
- May 5, 2026
More from Pfizer
- In developmentHow Investors May Respond To Pfizer (PFE) Phase 3 Cancer Trial WinIn development
- PatentsPfizer was granted a patent for multi-antigen pneumococcal vaccinesPatents
- RedditPfizer employees discuss ongoing and upcoming layoffs alongside updates to the company separation plan reducing healthcare and severance benefits starting next year.Reddit
- LayoffPfizer cuts 330 jobs in Italy as JPMorgan lifts target for Pfizer stockLayoff
- Web trafficpfizer.com traffic surged 23% to 2M monthly visits.Web traffic
- LinkedInPfizer Inc. promotes protection against Respiratory Syncytial Virus (RSV).LinkedIn
More 10-Q signals at other companies
- SEC 10-QAcadia Realty TrustAcadia Realty Trust amends credit facility, extending maturities and increasing capacity to $2.0 billionSEC 10-Q
- SEC 10-QAdvanced Energy Industries, Inc.Advanced Energy completed $1.15 billion convertible notes offering and redeemed 2028 NotesSEC 10-Q
- SEC 10-QAlexander's, Inc.Alexander's signs 15-year retail lease with Target for 135,000 square feet at Rego ParkSEC 10-Q
The full record
From the Signal API recordDetails
- CIK
- 78003
- Accession number
- 0000078003-26-000054
- Timeframe
- Current quarter
- Filing year
- 2026
- Fiscal year
- 0
- Why it matters
- Vendor review likely
- Signal category
- Financial
Extraction
- Confidence
- High
- Relevance
- 90%
- Sentiment
- Neutral
- Detected
- May 12, 2026
- signal_type
sec-10q- signal_subtype
restructuringCharge
Use this data
Get every 10-Q signal for Pfizer and the companies you sell to, in the tools you already use.
Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Pfizer this week?”
Send it to your own tools
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits
The API returns more than this page shows
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the API
Signal
signal_nameValue in the APIassociationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONHide the full JSONThe record on this page and the API request
GET /v1/signals/f931f957-ab68-4fe0-950e-e7b5b4d359fa returns this record as JSON. POST /v1/companies/enrich returns every signal for pfizer.com.
{
"signal_id": "f931f957-ab68-4fe0-950e-e7b5b4d359fa",
"signal_type": "sec-10q",
"signal_subtype": "restructuringCharge",
"detected_at": "2026-05-12T09:24:57.864+00:00",
"company": {
"name": "Pfizer",
"domain": "pfizer.com"
},
"data": {
"detail": "Following its recent acquisition of Metsera, Pfizer is incurring acquisition-related costs. Large-scale integrations often create needs for new systems, process harmonization, and organizational restructuring to realize synergies, presenting opportunities for consulting and technology vendors.",
"metrics": {
"timeframe": "current_quarter"
},
"summary": "Pfizer integrating Metsera acquisition from Nov 2025, incurring acquisition-related costs.",
"excerpts": "See Note 2 for a discussion of our acquisition of Metsera in November 2025 and other recent business development initiatives.",
"relevance": 0.9,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/78003/000007800326000054/pfe-20260329.htm",
"filing_date": "2026-05-05",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/29",
"sales_relevance": "Vendor review likely",
"signal_category": "financial"
}
}
curl https://signals.autobound.ai/v1/signals/f931f957-ab68-4fe0-950e-e7b5b4d359fa \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"pfizer.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.